MNPR
Monopar TherapeuticsยทNASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --
MNPR Profile
Monopar Therapeutics Inc.
A biotech company developing cancer and rare disease treatments in the US
Biological Technology
12/05/2014
12/19/2019
NASDAQ Stock Exchange
14
12-31
Common stock
1000 Skokie Blvd., Suite 350, Wilmette, IL 60091
--
Monopar Therapeutics Inc., originally incorporated in Delaware on December 5, 2014, is a limited liability company and was converted to a C company through a tax-free exchange on December 16, 2015, when the company conducted a 1 for 10 reverse stock split. The company is a clinical-stage biopharmaceutical company focused on developing innovative treatments for cancer patients.
